Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2020-004194-51Phase 3Active
Phase 3, randomised, open-label trial in atopic dermatitis (AD) comparing Cyclosporine monotherapy, Methotrexate monotherapy and Standard of care (3 arms). Primary endpoint: EASI75 at week 32. Started Nov 2020; status: active.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2020-004194-51.